ML604086

Products

Antibodies for IBD Research
Assay Kits for IBD Research
Inhibitors & Activators for IBD Research
Proteins & Peptides for IBD Research
Reported Gene Cell Lines for IBD Research

Inquiry

Cat. No.: IBDI-436207

ML604086 is a selective CCR8 inhibitor, inhibiting CCL1 binding to CCR8 on circulating T-cells. ML604086 inhibits CCL1 mediated chemotaxis and increases in intracellular Ca 2+ concentrations.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	CCR
Molecular Weight	508.63
Appearance	Solid
SMILES	O=C(NC1=C2C=CC=CC2=C(S(=O)(N[[email protected]]3[[email protected]](C)CN(C([[email protected]@H](N)C)=O)CC3)=O)C=C1)C4=CC=CC=C4C
Purity	99.80%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.